Cervical cancer screening has evolved significantly. Today there are three valid approaches: cytology (Pap smear) alone, HPV DNA testing alone, or co-testing (both together). The right choice depends on age, history, and personal preference — and the modern evidence increasingly favours HPV-based screening as the primary tool for women over 30.

The traditional Pap smear examines cervical cells for changes that may precede cancer. It catches dysplasia at a treatable stage and is recommended every 3 years for women aged 21–29. HPV DNA testing detects the actual viruses (high-risk types) that cause virtually all cervical cancer — it is more sensitive than Pap alone and, with a negative result, allows screening intervals to extend to 5 years.

Ask whether you need to be seen

Message us with what you are experiencing and we will tell you whether an examination is worth making, and what the appointment involves.

WhatsAppLINE

Co-testing — both at once — is considered the gold standard for women aged 30–65 in many guidelines. If both tests are negative, retest in 5 years. If either is positive, follow-up is more targeted. At THE FIT CLINIC we discuss your history, HPV vaccination status, and prior results to recommend the right combination. Together with HPV vaccination, modern screening has made cervical cancer one of the most preventable cancers in women — but only for those who get tested on schedule.